Can you stop TRT and get your fertility back? Here's the truth

What did @cbronsonmd actually say?

The doctor says he prefers HCG over selective estrogen receptor modulators (SERMs) like clomiphene when helping men recover fertility after TRT, or maintain it while on testosterone. He then describes two patients who stopped testosterone, started HCG plus clomiphene, saw their testosterone levels recover within three weeks, but reported "zero interest in sex" despite normal labs. His takeaway seems to be that good numbers don't mean you feel good.

That's the core claim here: SERMs are his second choice, HCG is his first, and even when the hormonal recovery looks clean on paper, libido can crater in ways the bloodwork won't explain. He's speaking from clinical anecdote, not a trial, which matters when you're evaluating how much weight to put on this.

Does the science back this up?

Mostly, yes. The preference for HCG over SERMs in this context has real biological logic behind it, and the libido-despite-normal-T complaint is well-documented in the literature. But the framing oversimplifies what's actually happening hormonally.

HCG (human chorionic gonadotropin) mimics luteinizing hormone (LH) and directly stimulates testicular function, including both testosterone and sperm production. This matters because exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, shutting down LH and FSH. HCG bypasses that suppression at the testicular level. A 2013 study by Hsieh et al. in the Journal of Urology showed that HCG can maintain intratesticular testosterone and spermatogenesis in men on TRT. That's solid support for using it.

Clomiphene (he mispronounces it repeatedly as "chlomaphine") works differently. It blocks estrogen receptors in the hypothalamus, tricking the brain into producing more LH and FSH. It raises total testosterone in hypogonadal men, confirmed by a 2003 Shabsigh et al. study in the Journal of Urology. But it also raises estrogen and can produce a hormonal environment that doesn't feel the same as either normal testosterone production or TRT. That estrogen elevation, plus the loss of exogenous testosterone's direct CNS effects, likely explains the libido problem he's describing.

What did they get wrong (or right)?

He gets the clinical observation right: libido is not simply a function of serum testosterone levels. This is one of the more underappreciated facts in men's health. Research by Isidori et al. (2005, Clinical Endocrinology) found that while testosterone has a threshold effect on libido, levels above that threshold don't predict desire, and other factors including estrogen balance, prolactin, psychological state, and relationship context all play roles.

What he gets wrong, or at least incomplete, is the explanation for why these two patients felt that way. He implies it's simply that clomiphene and HCG aren't as good as TRT for libido. That may be true for some men, but the mechanism matters. Clomiphene's anti-estrogenic effects at the hypothalamus can disrupt mood and libido even when testosterone looks fine. A 2019 review by Wheeler et al. in Sexual Medicine Reviews noted visual disturbances and mood changes as real adverse effects of clomiphene that are often underreported in clinical practice.

He also never mentions FSH or sperm analysis in the follow-up. If the goal is fertility, semen parameters matter more than serum testosterone levels looking "gorgeous."

What should you actually know?

If you're on TRT and thinking about fertility, the conversation is more layered than "stop testosterone, start HCG." Here's what the evidence actually supports.

• Stopping exogenous testosterone is typically necessary for spermatogenesis recovery, but recovery timelines vary widely. A 2020 study by Wenker et al. in the Journal of Urology found median time to sperm recovery after TRT discontinuation was around 6 months, with some men taking longer than a year.
• HCG alone or combined with FSH (or clomiphene to stimulate endogenous FSH) is a legitimate protocol for fertility preservation or recovery. Neither approach is universally superior. Patient-specific factors including baseline LH, FSH, and testicular function should drive the choice.
• Libido complaints on clomiphene are real and documented. If a patient reports no sex drive while trying to conceive, that's a clinical problem worth addressing, not just reassuring them that their labs look fine.
• "Feeling okay, not as good as I did on testosterone" is an expected and honest outcome to communicate to patients before they stop TRT. Setting that expectation is good medicine.

Talk to a provider who will order semen analysis, not just a testosterone panel, if fertility is the actual goal.